A Phase II Study of Single-Agent Gemcitabine as a Second-Line Treatment in Advanced Non-Small Cell Lung Cancer
Article in Japanese Journal of Clinical Oncology (January 2006)
The most recent citing publications are shown below. View all 2 publications that cite this research output on Dimensions.
A 21-day Schedule of Gemcitabine and Cisplatin Administration in the Treatment of Advanced Non-Small Cell Lung Carcinoma: a Phase II Study
Article in Cancer Research and Treatment (February 2004)